Pre-screening

DIAGNOSTIC_TEST2 trials

Sponsors

Technion, Israel Institute of Technology, Adrenas Therapeutics Inc

Conditions

Autism Spectrum Disorder (ASD)Congenital Adrenal Hyperplasia

Unknown Phase

Choice Switching and Autism

CompletedNCT04631432

Technion, Israel Institute of TechnologyAutism Spectrum Disorder (ASD)

Start: 2021-01-01End: 2021-09-13Updated: 2022-04-27

A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])

CompletedNCT05101902

Adrenas Therapeutics IncCongenital Adrenal Hyperplasia

Start: 2021-07-01End: 2024-08-07Updated: 2024-09-19

Related Papers

ODP046 Initial Lessons from a Prescreening Protocol to Identify Participants with Classic CAH Potentially Eligible for Gene Therapy Treatment with BBP-631, an Adeno-associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human CYP21A2 Gene

Journal of the Endocrine Society2022-11-011 citations